Investigation of the effect of interleukin-1 receptor antagonist on markers of inflammation in non-ST elevation acute coronary syndromes.

Trial Profile

Investigation of the effect of interleukin-1 receptor antagonist on markers of inflammation in non-ST elevation acute coronary syndromes.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Anakinra (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms MRC-ILA-HEART
  • Most Recent Events

    • 30 Jan 2014 United Kingdom Clinical Research Network reports accrual to date is 97%
    • 19 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 31 May 2012 Additional trial locations added as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top